Hepatitis B component does not interfere with the immune response to diphtheria, tetanus and whole-cell Bordetella pertussis components of a quadrivalent (DTPw-HB) vaccine: a controlled trial in healthy infants

This publication has 14 references indexed in Scilit:

• Immune response to a combined hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine administered to infants at 2, 4 and 6 months of age
  Vaccine, 1997
• Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations
  JAMA, 1995
• Evaluation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B candidate vaccine administered to healthy infants according to a three-dose vaccination schedule
  Vaccine, 1995
• Hepatitis B prevention in Europe: a preliminary economic evaluation
  Vaccine, 1995
• Global programme for control of hepatitis B infection
  Vaccine, 1995
• Should Canada and the United States Universally Vaccinate Infants against Hepatitis B?
  Medical Decision Making, 1993
• Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine
  Vaccine, 1990
• Natural History of Pertussis Antibody in the Infant and Effect on Vaccine Response
  The Journal of Infectious Diseases, 1990
• Estimation of Corynebacterium diphtheriae antitoxin in human sera: A comparison of an enzyme-linked immunosorbent assay with the toxin neutralisation test
  Journal of Medical Microbiology, 1988
• A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera
  Journal of Biological Standardization, 1983